Overview

Effectiveness of Antibiotics Versus Placebo to Treat Antenatal Hydronephrosis

Status:
Active, not recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study focuses on the relationship between prophylaxis antibiotics and frequency of urinary tract infection in children diagnosed with antenatal hydronephrosis. Hydronephrosis is the most common fetal abnormality occurring in 1-5% of all pregnancies. Currently, with the widespread accessibility of antenatal ultrasound across cities in Ontario, the detection of hydronephrosis has become even more common. As a result, thousands of infants with hydronephrosis have been seen and managed by pediatricians, pediatric nephrologists, pediatric urologists, and family physicians. The investigators need to determine if antibiotic prophylaxis is effective in reducing the number of urinary tract infections in this population.
Phase:
N/A
Details
Lead Sponsor:
McMaster University
Collaborators:
Hamilton Health Sciences Corporation
McMaster Surgical Associates
The Physicians' Services Incorporated Foundation
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Trimethoprim